scanance.
Sign inGet Premium
CG

Cognex Corporation

CGNXTechnologyNASDAQ

Scientific & Technical Instruments · Last scanned May 29, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot
MA150+40.06%
$47.13

Price above medium-term moving average.

MA200+41.96%
$46.50

Above long-term trend line.

RSI-14neutral
50.4

Balanced. Not overbought, not oversold.

MACDnegative
-0.0001

Histogram negative — downward momentum.

Financials · Annual
Revenue
$994.4M
+8.7% YoY
Net Income
$114.4M
+7.8% YoY
EBITDA
$193.4M
+30.9% YoY
Free Cash Flow
$181.4M

Scan Results

Daily timeframe

1 of 4 indicators bearish as of May 28

DateIndicatorDetails
Loading...
About Cognex Corporation

Part of the technology sector, Cognex Corporation (CGNX) is listed under Scientific & Technical Instruments. With a market capitalization of $10.99B, it sits in large-cap territory. Its machine vision products are used to automate the manufacture and distribution of discrete items, such as mobile phones, automotive components, and e-commerce packages, by locating, identifying, inspecting, and measuring them.

Key stats
Market Cap$10.99B
P/E (TTM)77.66
Fwd P/E37.47
EPS$0.85
Beta1.48
52W Change+120.2%
Dividend Yield0.51%
ROE9.8%
Analysis

With $296.8M in cash and $74.0M in debt, CGNX maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Annual free cash flow of $181.4M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 9.8%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 6.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $1.01B (2022) to $994.4M (2025).

With cash comfortably exceeding debt, CGNX has financial flexibility that may help navigate uncertain periods. At over 50x earnings, CGNX carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. No single metric tells the full story. Reviewing CGNX's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms